Motiva Ergonomix2 Platform and Motiva Mia Implant Receive CE Mark
14 déc. 2020 08h00 HE
|
Establishment Labs Holdings Inc.
Commercial Launch of Ergonomix2 Planned for 2021Approval Accelerates Path to Europe for Motiva MiaPre-Commercial European Mia Procedures to Begin in Second Half of 2021 SANTA BARBARA, Calif.,...
Establishment Labs Completes 21 Motiva Mia Patients in IRB Approved Study in Costa Rica
10 déc. 2020 08h00 HE
|
Establishment Labs Holdings Inc.
IRB Approval Includes Both the Ergonomix2 Diamond Implant and Mia Tools SANTA BARBARA, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical...
Establishment Labs to Participate in Two Upcoming Investment Conferences
10 nov. 2020 08h00 HE
|
Establishment Labs Holdings Inc.
SANTA BARBARA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics...
Establishment Labs Reports Third Quarter 2020 Financial Results
09 nov. 2020 16h05 HE
|
Establishment Labs Holdings Inc.
SANTA BARBARA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics...
Establishment Labs Celebrates 10 Years of Motiva Safety Data
21 oct. 2020 08h00 HE
|
Establishment Labs Holdings Inc.
Findings Show Less Than 1% Device Related ComplicationsNearly 1.3 Million Implants Placed Worldwide SANTA BARBARA, Calif., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc....
Establishment Labs Reports Preliminary Third Quarter Revenue and Cash Balance
21 oct. 2020 08h00 HE
|
Establishment Labs Holdings Inc.
$22 million to $23 million 3rd Quarter Preliminary RevenueCash Balance at September 30, 2020 an Estimated $81.0 millionCompany to Announce Full 3rd Quarter Results on November 9 SANTA BARBARA,...
Establishment Labs to Celebrate 10 Years of Motiva Safety Data at Plastic Surgeon Virtual Symposium
07 oct. 2020 16h45 HE
|
Establishment Labs Holdings Inc.
SANTA BARBARA, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics...
Establishment Labs Finalizes Distribution Agreement with Puregraft LLC
25 sept. 2020 09h00 HE
|
Establishment Labs Holdings Inc.
SANTA BARBARA, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics...
Establishment Labs Announces Independent Publication Detailing New Advancements in Hybrid Breast Reconstruction Technique Using Motiva Ergonomix Implants
21 sept. 2020 08h00 HE
|
Establishment Labs Holdings Inc.
SANTA BARBARA, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics...
ESTA Announces Participation in the Wells Fargo Virtual Healthcare Conference
02 sept. 2020 08h00 HE
|
Establishment Labs Holdings Inc.
NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and...